Adam Koppel - Dec 2, 2022 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Director, 10%+ Owner
Signature
/s/ Adam Koppel
Stock symbol
SLDB
Transactions as of
Dec 2, 2022
Transactions value $
$0
Form type
4
Date filed
12/5/2022, 04:16 PM
Previous filing
Jun 22, 2022
Next filing
Dec 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLDB Director Stock Option (Right to Buy) Award $0 +2.67K $0.00 2.67K Dec 2, 2022 Common Stock 2.67K $6.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on December 2, 2022 and vests in full on the one-year anniversary of the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.